Coronary artery disease in hypertension

Journal Title: Przewodnik Lekarza - Year 2006, Vol 83, Issue 1

Abstract

Arterial hypertension is one of the main risk factors in the development of coronary artery disease (CAD). Values of blood pressure in patients with CAD and arterial hypertension should be the same as in hypertonic patients without CAD. Great role in hypertension treatment of patients with CAD is played by nonfarmacological treatment. It lowers blood pressure and has a positive effect on other modificable risk factors in the development of CAD In farmacological treatment it is possible to use all groups of hypertension medications. In order to select a proper treatment we take into account the efficiency of a heart and any contraindications for using the preparation. In primary prevention of coronary artery disease for hypertonic patients is suggested to use angiotensin converting enzyme and calcium blockers. In secondary prevention we use β-blockers and angiotensin converting antagonism enzyme.

Authors and Affiliations

Anna Boruczkowska

Keywords

Related Articles

Management in peripheral arterial disease

Peripheral arterial disease (PAD) is the chronic obstruction of the arteries supplying the lower extremities. PAD is a manifestation of systemic atherosclerosis that is associated with an increased risk of death and is...

Does tuberculosis remain a social problem?

With approximately 3 million annual deaths, tuberculosis (TB) remains a leading cause of mortality worldwide into the 21st century. It is estimated that one third of the world population harbor a latent infection by the...

Chemoprewencja raka jelita grubego

Rak jelita grubego jest nowotworem o wysokiej śmiertelności, co wiąże się z późnym rozpoznaniem wielu jego przypadków. Działanie ukierunkowane na zmniejszenie zachorowalności i śmiertelności koncentruje się przede wszys...

The effect of characteristic of pulmonary delivery devices and drug formulation on lung deposition and efficacy of inhalant therapy

The pulmonary drug delivery shows numerous advantages over other routes of administration. The major advantage is the high drug concentration in the lungs and low concentration in serum. Consequently, the systemic side e...

Otyłość – choroba interdyscyplinarna

Otyłość staje się światową epidemią. Z roku na rok stale wzrasta liczba osób, u których rozpoznaje się nadwagę i leczy jej następstwa. Otyłość stanowi istotny czynnik rozwoju chorób układu krążenia i oddechowego, zaburze...

Download PDF file
  • EP ID EP133886
  • DOI -
  • Views 101
  • Downloads 0

How To Cite

Anna Boruczkowska (2006). Coronary artery disease in hypertension. Przewodnik Lekarza, 83(1), 26-33. https://europub.co.uk/articles/-A-133886